HOME >> BIOLOGY >> NEWS
Vaccine trials inject hope into koala's future

The first Australian trials of a vaccine developed by Queensland University of Technology that could save Australia's iconic koala from contracting chlamydia are planned to begin later this year.

Professor Peter Timms, from QUT's Institute of Health and Biomedical Innovation, said chlamydia was a major threat to the continued survival of koalas with almost all populations affected by the disease.

"The trial is planned to begin before the end of the year and will test the vaccine's ability to induce a good immune response in the koala against chlamydia," he said.

"Assuming that this first trial is successful, then future trials can determine if this immune response is able to protect the koalas against chlamydial disease.

"We've been able to develop the vaccine for koalas as a result of our studies on the development of human chlamydial vaccines done in the mouse model. We have identified several novel vaccine proteins that we hope will protect koalas as well."

Professor Timms said chlamydia in koalas was a significant cause of infertility, urinary tract infections, and inflammation in the lining of the eye that often led to blindness.

"The numbers of koalas with chlamydia seems to be increasing," he said.

"As much as 40-50 per cent of koalas coming into care in both Queensland and NSW are showing clinical signs of the disease and it seems to be getting worse."

The vaccine will be administered to a small number of koalas via an injection either under the skin or intramuscularly.

"The first phase of the trial will run for between six and 12 months," he said.

"We will have initial results within the first six months but we will continue to monitor the koalas for 12 months to determine how long the vaccine stimulates an immune response in the koalas and whether or not a booster shot is required.

"There is no danger that a koala without chlamydia will contra
'"/>

Contact: Sandra Hutchinson
s3.hutchinson@qut.edu.au
61-731-382-130
Queensland University of Technology
16-Jul-2007


Page: 1 2

Related biology news :

1. Vaccine hope for malaria
2. Vaccine prevents prion disease in mice
3. Vaccine hope for sufferers of potentially fatal stomach bug
4. Vaccine to cope with viral diversity in HIV
5. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
6. U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication
7. Vaccine-producing plant-factories
8. HPV Vaccine: Whats next
9. Vaccine shown effective against chancroid
10. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
11. Vaccine provides 100 percent protection against avian flu virus in animal study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric ... Group (CEG) to market and sell its complete line of biometric readers and ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales ...
(Date:5/25/2020)... ... May 22, 2020 , ... Oxford Nanopore Technologies is ... of SARS-CoV-2, the virus that causes COVID-19. , The LamPORE assay is ... smaller sample numbers, to very large numbers of samples. Hardware and reagents sit ...
(Date:5/21/2020)... ... 21, 2020 , ... Agility Orthopedics, home to dedicated specialists ... is pleased to announce a partnership with Dallas-based Simple Interact to further enhance ... area, Agility Orthopedics is focused on speeding up patient workflows to enhance patient ...
Breaking Biology News(10 mins):
(Date:5/1/2020)... NEW YORK (PRWEB) , ... April 30, 2020 ... ... Ideas Awards were announced today, honoring the businesses, policies, projects, and concepts that ... is a revolutionary bioprinter for living cells, which has taken out the top ...
(Date:4/23/2020)... ... April 22, 2020 , ... Across the country, there is ... COVID-19. Virginia has only been receiving 50% to 7.7% of the personal protective ... Governor Northam told the Virginia Mercury, “While we appreciate what we’ve received from ...
(Date:4/22/2020)... ... April 21, 2020 , ... Aniara Diagnostica is pleased ... , Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well ... product quality and cost-efficient delivery. , For Research Use Only. Not ...
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Research (SBIR) program to support the expansion of its digital health platform enabling ... conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government awards ...
Breaking Biology Technology:
Cached News: